Literature DB >> 28658329

Impact of non-adherent Ibuprofen foam dressing in the lives of patients with venous ulcers.

Geraldo Magela Salomé1, Lydia Masako Ferreira1.   

Abstract

Objective: to evaluate pain in patients with lower limb venous ulcer who used non-adherent Ibuprofen foam dressing (IFD).
Methods: we conducted a prospective study of patients with lower limb venous ulcers treated from April 2013 to August 2014. We used the Numerical Scale and McGill Pain Questionnaire, performing the assessments at the moment of inclusion of the patient in the study and every eight days thereafter, totaling five consultations. We divided the patients into two groups: 40 in the Study Group (SG), who were treated with IFD, and 40 in the Control Group (CG), treated with primary dressing, according to tissue type and exudate.
Results: at the first consultation, patients from both groups reported intense pain. On the fifth day, SG patients reported no pain and the majority of CG reported moderate pain. Regarding the McGill Pain Questionnaire, most patients of both groups reported sensations related to sensory, affective, evaluative and miscellaneous descriptors at the beginning of data collection; after the second assessment, there was slight improvement among the patients in the SG. After the third consultation, they no longer reported the mentioned descriptors. CG patients displayed all the sensations of these descriptors until the fifth visit.
Conclusion: non-adherent Ibuprofen foam dressing is effective in reducing the pain of patients with venous ulcers.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28658329     DOI: 10.1590/0100-69912017002002

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  1 in total

1.  Virtual Reality-Based Analysis of Pressure Ulcer Care Information Related to Medical Equipment for the Prevention of Pressure Ulcer Skin Foam Dressings in the Elderly.

Authors:  Na Zhao; Zhanhong Tian; Yang Li; Haihua Yu; Yu Yang
Journal:  J Healthc Eng       Date:  2021-11-09       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.